Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 6 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 3 Lung Neoplasms 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Neoplasm Metastasis 2 Cholangiocarcinoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Oligometastatic Prostate Cancer 1 Neoplasms 1 Metastatic Urothelial Cancer 1 Melanoma 1 Locally Advanced Pancreatic Cancer 1 Locally Advanced Cervical Cancer 1 Liver Neoplasms 1 Liposarcoma 1 Kidney Neoplasms 1 Gestational Trophoblastic Disease 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

Oxaliplatin 146 Fluorouracil 137 Capecitabine 122 Leucovorin 106 Irinotecan 85 Radiotherapy 67 Bevacizumab 64 Cetuximab 46 Folfox protocol 28 Surgical Procedures, Operative 23 Radiation 23 Drug Therapy 22 Panitumumab 19 XELOX 18 Chemotherapy, Adjuvant 15 Neoadjuvant Therapy 14 Radiotherapy, Intensity-Modulated 13 Chemoradiotherapy 13 Magnetic Resonance Spectroscopy 11 regorafenib 10 Nivolumab 10 Floxuridine 10 sintilimab 8 raltitrexed 8 Specimen Handling 8 IFL protocol 8 Celecoxib 8 Biopsy 8 trifluridine tipiracil drug combination 7 tislelizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Rectal Neoplasms × zimberelimab × Clear all

NCT05024097 2025-08-27

PANTHER

Weill Medical College of Cornell University

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡